TY - JOUR
T1 - Thromboelastography parameters in patients with acute on chronic liver failure
AU - Goyal, Sandeep
AU - Jadaun, Shekhar
AU - Kedia, Saurabh
AU - Kumar-Acharya, Subrat
AU - Varma, Sharat
AU - Nayak, Baibaswata
AU - Thakur, Bhaskar
AU - Shalimar, M. D.
N1 - Publisher Copyright:
© 2018, Fundacion Clinica Medica Sur. All rights reserved.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Introduction and aim. Patients with acute on chronic liver failure (ACLF) have abnormal conventional coagulation tests-platelet count and international normalized ratio (INR). Thromboelastography (TEG) is a rapid, point-of-care assay, more comprehensive than platelet count and INR as it assesses for platelet adequacy (number and function), coagulation factors and clot retraction. The aim of the study was to evaluate the TEG parameters in patients with ACLF, chronic liver disease having acute decompensation (AD) and healthy subjects (HC). Material and methods. TEG parameters were assessed in patients with ACLF and AD within 24 h of admission. Consecutive patients were included in the study over 12 months. Healthy subjects were recruited as controls. Results. 179 patients were included-68 ACLF, 53 AD and 58 HC. The mean values of INR in ACLF, AD and HC groups were 2.9 ± 1.4, 1.6 ± 0.4 and 1.1 ± 0.2; P < 0.001. Among TEG parameters-maximum amplitude (MA) was low in ACLF and AD patients as compared with HC (53.8 ± 15, 58.3 ± 13.9 mm and 67.2 ± 12.1 mm, respectively; P < 0.001). Lysis at 30 min (LY30) was high in ACLF patients, as compared to AD and HC (8.6 ± 14.1%, 5.0 ± 9.5% and 4.9 ± 9.8%, respectively; P = 0.060). There were no differences in r time, k time, and alpha angle between groups; normal in >90% patients. There was no difference in TEG parameters between different ACLF grades, whereas CCTs were more deranged with increasing grades of ACLF. Conclusion. Despite abnormal conventional coagulation tests, TEG parameters in ACLF patients are essentially normal, except reduced maximum amplitude. Future studies are needed to explore the utility of TEG in clinical management of ACLF patients.
AB - Introduction and aim. Patients with acute on chronic liver failure (ACLF) have abnormal conventional coagulation tests-platelet count and international normalized ratio (INR). Thromboelastography (TEG) is a rapid, point-of-care assay, more comprehensive than platelet count and INR as it assesses for platelet adequacy (number and function), coagulation factors and clot retraction. The aim of the study was to evaluate the TEG parameters in patients with ACLF, chronic liver disease having acute decompensation (AD) and healthy subjects (HC). Material and methods. TEG parameters were assessed in patients with ACLF and AD within 24 h of admission. Consecutive patients were included in the study over 12 months. Healthy subjects were recruited as controls. Results. 179 patients were included-68 ACLF, 53 AD and 58 HC. The mean values of INR in ACLF, AD and HC groups were 2.9 ± 1.4, 1.6 ± 0.4 and 1.1 ± 0.2; P < 0.001. Among TEG parameters-maximum amplitude (MA) was low in ACLF and AD patients as compared with HC (53.8 ± 15, 58.3 ± 13.9 mm and 67.2 ± 12.1 mm, respectively; P < 0.001). Lysis at 30 min (LY30) was high in ACLF patients, as compared to AD and HC (8.6 ± 14.1%, 5.0 ± 9.5% and 4.9 ± 9.8%, respectively; P = 0.060). There were no differences in r time, k time, and alpha angle between groups; normal in >90% patients. There was no difference in TEG parameters between different ACLF grades, whereas CCTs were more deranged with increasing grades of ACLF. Conclusion. Despite abnormal conventional coagulation tests, TEG parameters in ACLF patients are essentially normal, except reduced maximum amplitude. Future studies are needed to explore the utility of TEG in clinical management of ACLF patients.
KW - Acute decompensation
KW - Cirrhosis
KW - Conventional coagulation parameters
KW - Hemostasis
KW - Liver failure
UR - http://www.scopus.com/inward/record.url?scp=85059408691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059408691&partnerID=8YFLogxK
U2 - 10.5604/01.3001.0012.7205
DO - 10.5604/01.3001.0012.7205
M3 - Article
C2 - 30600294
AN - SCOPUS:85059408691
SN - 1665-2681
VL - 17
SP - 1042
EP - 1051
JO - Annals of Hepatology
JF - Annals of Hepatology
IS - 6
ER -